Gore Acquires Pipeline Medical Technologies, Inc.

Acquisition of transcatheter mitral chordal repair technology builds on Gore’s structural heart capabilities

First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry

Investigator initiated EXCeL Registry will assess safety and abdominal aortic aneurysm treatment success in patients with challenging anatomies

GORE REDUCE CLINICAL STUDY FIVE-YEAR RESULTS DEMONSTRATE THAT PFO CLOSURE WITH THE GORE® CARDIOFORM SEPTAL OCCLUDER PROVIDES SAFE LONG-TERM REDUCTION OF RECURRENT STROKE

Gore Unveils Next Evolution for TIPS Procedures: Lasting Diameter Control

GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion builds on a legacy of proven patency

Gore Marks 20th Year on 100 Best Companies to Work For® List

Gore has appeared in every edition of the rankings, published annually in Fortune magazine. The company is among just 12 “Great Place to Work Legends” to hold this distinction.

FDA Approves GORE® VIABAHN® Endoprosthesis for Revision of the Arteriovenous Access

Flexibility and Durability to Aid Hemodialysis Patients

Gore REDUCE Clinical Study Completes Enrollment

Study of Closure of Patent Foramen Ovale (PFO) in Stroke Patients Reaches Major Milestone

Gore Recognized as one of the Worlds Best Multinational Workplaces by Great Place to Work®

Company earns No. 3 spot

Gore Joins Americas Hernia Society Quality Collaborative (AHSQC) as Silver Sponsor

Partnership latest step in Gore’s ongoing commitment to improve quality of care for hernia patients

Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment

Over 5,000 patients from 114 worldwide sites provide a unique perspective of real-world conditions